The effect of pharmacist-provided non-dispensing services on patient outcomes, health service utilisation and costs in low- and middle-income countries

Cochrane Database of Systematic Reviews

Volumn 2013, Issue 2, 2013, Pages

  Pande, Sami ^a   Hiller, Janet E ^b   Nkansah, Nancy ^c   Bero, Lisa ^c  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b AUSTRALIAN CATHOLIC UNIVERSITY   (Australia)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASTHMA; BLOOD PRESSURE; CHOLESTEROL BLOOD LEVEL; CLINICAL OUTCOME; COST CONTROL; DIABETIC PATIENT; EMERGENCY WARD; EXPIRATORY FLOW RATE; GENERAL PRACTICE; GLUCOSE BLOOD LEVEL; HEALTH CARE COST; HEALTH CARE DELIVERY; HEALTH CARE PERSONNEL; HEALTH CARE UTILIZATION; HEALTH SERVICE; HOSPITALIZATION; HUMAN; INTERMETHOD COMPARISON; LOW INCOME COUNTRY; MIDDLE INCOME COUNTRY; PHARMACIST; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SYSTEMATIC REVIEW; TRIACYLGLYCEROL BLOOD LEVEL; COST; DEVELOPING COUNTRY; HEALTH PROMOTION; HEALTH STATUS; META ANALYSIS; METHODOLOGY; PHARMACY; PROFESSIONAL STANDARD; STATISTICS; TREATMENT OUTCOME; UTILIZATION REVIEW;

COSTS AND COST ANALYSIS; DEVELOPING COUNTRIES; HEALTH PROMOTION; HEALTH SERVICES; HEALTH STATUS; HUMANS; PHARMACEUTICAL SERVICES; PROFESSIONAL ROLE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME;

EID: 84885041292     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD010398     Document Type: Review

References (132)

1. Abdelhamid E, Awad A, Gismallah A. Evaluation of a hospital pharmacy-based pharmaceutical care services for asthma patients. Pharmacy Practice 2008, issue 1:25-32.
2. Adepu R, Rasheed A, Nagavi B. Effect of patient counseling on quality of life in type-2 diabetes mellitus patients in two selected South Indian community pharmacies: A study. Indian Journal of Pharmaceutical Sciences 2007; Vol. 69, issue 4:519-24.
3. Arun K, Murugan R, Kanna M, Rajalakshmi S, Kalaiselvi R, Komathi V. The impact of pharmaceutical care on the clinical outcome of diabetes mellitus among a rural patient population. International Journal of Diabetes in Developing Countries 2008; Vol. 28, issue 1:15-8.
4. Ebid AH, Abdel-Wahab E. Bronchial asthma and COPD: Impact of pharmaceutical care on outcomes and quality of life in Egyptian patients. Bulletin of Pharmaceutical Sciences 2006; Vol. 29, issue Part 1:167-85.
5. Gonzalez-Martin G, Joo I, Sanchez I. Evaluation of the impact of a pharmaceutical care program in children with asthma. Patient Education and Counseling. 2003/01/16 2003; Vol. 49, issue 1:13-8. [0738-3991: (Print)]
6. Lugo De Ortellado G, de Bittner MR, Chavez H, Perez S. Implementation of a pharmaceutical care program for the detection of hypertension and drug therapy to be followed up in community pharmacies. Acta Farmaceutica Bonaerense 2007; Vol. 26, issue 4:590-5.
7. Paulos CP, Nygren CE, Celedon C, Carcamo CA. Impact of a pharmaceutical care program in a community pharmacy on patients with dyslipidemia. The Annals of Pharmacotherapy. 2005/04/14 2005; Vol. 39, issue 5:939-43. [1060-0280: (Print)]
8. Petkova VB. Pharmaceutical care for asthma patients: A community pharmacy-based pilot project. Allergy and Asthma Proceedings 2008; Vol. 29, issue 1:55-61.
9. Petkova VB. Education for arthritis patients: A community pharmacy based pilot project. Pharmacy Practice 2009; Vol. 7, issue 2:88-93.
10. Sookaneknun P, Richards RM, Sanguansermsri J, Teerasut C. Pharmacist involvement in primary care improves hypertensive patient clinical outcomes. The Annals of Pharmacotherapy 2004, issue 12:2023-8.
11. Suppapitiporn S, Chindavijak B, Onsanit S. Effect of diabetes drug counseling by pharmacist, diabetic disease booklet and special medication containers on glycemic control of type 2 diabetes mellitus: a randomized controlled trial. Journal of the Medical Association of Thailand. 2006/04/21 2005; Vol. 88 Suppl 4:S134-41. [0125-2208: (Print)]
12. Zwarenstein M, Bheekie A, Lombard C, Swingler G, Ehrlich R, Eccles M, et al.Educational outreach to general practitioners reduces children's asthma symptoms: A cluster randomised controlled trial. Implementation Science 2007; Vol. 2:30.
13. Abu Rumman K, Ottmani S, Abu Sabra N, Baghdadi S, Seita A, Blanc L. Training on the practical approach to lung health: effect on drug prescribing in PHC settings in Jordan. Eastern Mediterranean Health Journal. 2009/05/28 2009; Vol. 15, issue 1:111-21. [1020-3397: (Print)]
14. Aguwa CN, Ukwe CV, Ekwunife OI. Effect of pharmaceutical care programme on blood pressure and quality of life in a Nigerian pharmacy. Pharmacy World & Science. 2007/08/19 2008; Vol. 30, issue 1:107-10. [0928-1231: (Print)]
15. Agyepong IA, Ansah E, Gyapong M, Adjei S, Barnish G, Evans D. Strategies to improve adherence to recommended chloroquine treatment regimes: a quasi-experiment in the context of integrated primary health care delivery in Ghana. Social Science & Medicine. 2002/11/01 2002; Vol. 55, issue 12:2215-26. [0277-9536: (Print)]
16. Akoria OA, Isah AO. Prescription writing in public and private hospitals in Benin City, Nigeria: the effects of an educational intervention. The Canadian Journal of Clinical Pharmacology. 2008/07/22 2008; Vol. 15, issue 2:e295-305. [1710-6222: (Electronic)]
17. Alam K, Palaian S, Shankar RP, Bista D, Mishra P, Prabhu MM. Role of pharmacist in counseling asthma patients. Pharmacy Times 2007; Vol. 39, issue 6:13-8.
18. Anderson RJ. Cost analysis of a managed care decentralized outpatient pharmacy anticoagulation service. Journal of Managed Care Pharmacy 2004; Vol. 10, issue 2:159-65.
19. Angalakuditi MV, Sunderland VB. Liquid medication dosing errors: A pre-post time series in India. International Journal of Pharmacy Practice 2003; Vol. 11, issue 2:105-10.
20. Angunawela II, Diwan VK, Tomson G. Experimental evaluation of the effects of drug information on antibiotic prescribing: a study in outpatient care in an area of Sri Lanka. International Journal of Epidemiology. 1991/06/01 1991; Vol. 20, issue 2:558-64. [0300-5771: (Print)]
21. Aramwit P, Assawawitoontip S. Evaluation of patient counseling on blood pressure control of out-patients with hypertension at Chulalongkorn Hospital. Journal of the Medical Association of Thailand 2003; Vol. 86 Suppl 2:496-500.
22. Armando PD, Semería N, Tenllado MI, Sola N. Dáder program in Argentina: Results of the first trimester activities. Pharmaceutical Care Espana 2001; Vol. 3, issue 3:196-203.
23. Armando P, Semería N, Tenllado M, Sola N. Pharmacotherapeutic follow-up of patients in community pharmacies. Seguimiento Farmacoterapéutico de Pacientes en Farmacias Comunitarias 2005; Vol. 36, issue 3:129-34.
24. Awad AI, Eltayeb IB, Baraka OZ. Changing antibiotics prescribing practices in health centers of Khartoum State, Sudan. European Journal of Clinical Pharmacology. 2006/01/04 2006; Vol. 62, issue 2:135-42. [0031-6970: (Print)]
25. Beaton SJ, Nag SS, Gunter MJ, Gleeson JM, Sajjan SS, Alexander CM. Adequacy of glycemic, lipid, and blood pressure management for patients with diabetes in a managed care setting. Diabetes Care 2004; Vol. 27, issue 3:694-8.
26. Birrell G, Birrell KG. Assessment of a 1-year teaching programme in Zanzibar, Tanzania. Lancet. 2000/09/29 2000; Vol. 356, issue 9235:1084. [0140-6736: (Print)]
27. Botha JH, Tyrannes I, Miller R, Wesley AG. Pharmacokinetic consultation program in a pediatric asthma clinic. American Journal of Hospital Pharmacy 1992; Vol. 49, issue 8:1936-40.
28. Brimkulov N, Ottmani SE, Pio A, Chubakov T, Sultanova A, Davletalieva N, et al.Feasibility test results of the Practical Approach to Lung Health in Bishkek, Kyrgyzstan. The International Journal of Tuberculosis and Lung Disease. 2009/04/02 2009; Vol. 13, issue 4:533-9. [1027-3719: (Print)]
29. Castro-Rios A, Reyes-Morales H, Perez-Cuevas R. [An evaluation of a continuing medical education program for primary care services in the prescription of hypoglycemic agents in diabetes mellitus type 2]. Salud Publica de Mexico. 2008/12/17 2008; Vol. 50 Suppl 4:S445-52. [1606-7916: (Electronic)]
30. Chaikoolvatana A, Chanakit T, Juengrakpong A. The evaluation of a recurrent Adverse Drug Reaction Prevention Program in the north-east region of Thailand. Journal of the Medical Association of Thailand. 2006/06/08 2006; Vol. 89, issue 5:699-705. [0125-2208: (Print)]
31. Chaiyakunapruk N, Laowakul A, Karnchanarat S, Pikulthong N, Ongphiphadhanakul B. Community pharmacy-based implementation and evaluation of an osteoporosis self-assessment tool for Asians. Journal of the American Pharmaceutical Association. 2006/06/03 2006; Vol. 46, issue 3:391-6. [1544-3191: (Print)]
32. De Andrade TU, Burini DM, Mello MDO, Bersácula NDS, Saliba RAD, Bravim FT, et al.Evaluation of the satisfaction level of patients attended by a pharmaceutical care program in a private communitarian pharmacy in Vitória (ES, Brazil). Revista Brasileira de Ciencias Farmaceuticas/Brazilian Journal of Pharmaceutical Sciences 2009; Vol. 45, issue 2:349-55.
33. De Lyra Jr DP, Marcellini PS, Pelá IR. Effect of pharmaceutical care intervention on blood pressure of elderly outpatients with hypertension. Revista Brasileira de Ciencias Farmaceuticas/Brazilian Journal of Pharmaceutical Sciences 2008; Vol. 44, issue 3:451-7.
34. De Souza WA, Yugar-Toledo JC, Bergsten-Mendes G, Sabha M, Moreno Jr H. Effect of pharmaceutical care on blood pressure control and health-related quality of life in patients with resistant hypertension. American Journal of Health-System Pharmacy 2007; Vol. 64, issue 18:1955-61.
35. Domecq C, Apud P, Paulos C. Evaluation of an educational program on ambulatory patients consuming histamine H2-receptor antagonists. Acta Farmaceutica Bonaerense 1991; Vol. 10, issue May-Aug:97-104.
36. Dowse R, Ehlers MS. The evaluation of pharmaceutical pictograms in a low-literate South African population. Patient Education and Counseling 2001; Vol. 45, issue 2:87-99.
37. Dowse R, Ehlers M. Medicine labels incorporating pictograms: do they influence understanding and adherence?. Patient Education and Counseling. 2005/06/14 2005; Vol. 58, issue 1:63-70. [0738-3991: (Print)]
38. Dubey AK, Palaian S, Shankar PR, Mishra P, Prabhu M, Bhandari RB, et al.Introduction to medication errors and the error prevention initiatives in a teaching hospital in Western Nepal. Pakistan Journal of Pharmaceutical Sciences 2006; Vol. 19, issue 3:244-51.
39. Eltayeb IB, Awad AI, Mohamed-Salih MS, Daffa-Alla MA, Ahmed MB, Ogail MA, et al.Changing the prescribing patterns of sexually transmitted infections in the White Nile Region of Sudan. Sexually Transmitted Infections. 2005/10/04 2005; Vol. 81, issue 5:426-7. [1368-4973: (Print)]
40. Erhun WO, Agbani EO, Bolaji EE. Positive benefits of a pharmacist-managed hypertension clinic in Nigeria. Public Health 2005, issue 9:792-8.
41. Esmaily HM, Savage C, Vahidi R, Amini A, Dastgiri S, Hult H, et al.Does an outcome-based approach to continuing medical education improve physicians' competences in rational prescribing?. Medical Teacher. 2009/11/17 2009; Vol. 31, issue 11:e500-6. [1466-187X: (Electronic)]
42. Garjani A, Salimnejad M, Shamsmohamadi M, Baghchevan V, Vahidi RG, Maleki-Dijazi N, et al.Effect of interactive group discussion among physicians to promote rational prescribing. Eastern Mediterranean Health Journal. 2009/06/27 2009; Vol. 15, issue 2:408-15. [1020-3397: (Print)]
43. Gonzalez Ochoa E, Armas Perez L, Bravo Gonzalez JR, Cabrales Escobar J, Rosales Corrales R, Abreu Suarez G. Prescription of antibiotics for mild acute respiratory infections in children. Bulletin of the Pan American Health Organization. 1996/06/01 1996; Vol. 30, issue 2:106-17. [0085-4638: (Print)]
44. Greenberg HM, Galyavich AS, Ziganshina LE, Tinchurina MR, Chamidullin AG, Farmer RG. Identification and management of patients with hypertension in the polyclinic system of the Russian Federation. American Journal of Hypertension 2005; Vol. 18, issue 7:943-8.
45. Gupta U, Sharma S, Sheth PD, Jha J, Chaudhury RR. Improving medicine usage through patient information leaflets in India. Tropical Doctor. 2005/08/18 2005; Vol. 35, issue 3:164-6. [0049-4755: (Print)]
46. Gutierrez G, Guiscafre H, Bronfman M, Walsh J, Martinez H, Munoz O. Changing physician prescribing patterns: evaluation of an educational strategy for acute diarrhea in Mexico City. Medical Care. 1994/05/01 1994; Vol. 32, issue 5:436-46. [0025-7079: (Print)]
47. Jing YS, Lai PSM, Siew SC, Siew PC. The impact of pharmacist intervention on the use of activated vitamin D in a tertiary referral hospital in Malaysia. International Journal of Pharmacy Practice 2009; Vol. 17, issue 5:305-11.
48. Lyra DP Jr, Rocha CE, Abriata JP, Gimenes FR, Gonzalez MM, et al.Influence of Pharmaceutical Care intervention and communication skills on the improvement of pharmacotherapeutic outcomes with elderly Brazilian outpatients. Patient Education and Counseling. 2007/08/19 2007; Vol. 68, issue 2:186-92. [0738-3991: (Print)]
49. Mao Y, Zhang Y, Zhai S. Mobile phone text messaging for pharmaceutical care in a hospital in China. Journal of Telemedicine and Telecare 2008; Vol. 14, issue 8:410-4.
50. Me'emary F, Ottmani SE, Pio A, Baghdadi S, Assafin G, Koraym M, et al.Results of the feasibility test of the Practical Approach to Lung Health in the Syrian Arab Republic. Eastern Mediterranean Health Journal. 2009/09/08 2009; Vol. 15, issue 3:504-15. [1020-3397: (Print)]
51. Meyer JC, Summers RS, Moller H. Randomized, controlled trial of prescribing training in a South African province. Medical Education. 2001/09/14 2001; Vol. 35, issue 9:833-40. [0308-0110: (Print)]
52. Mohagheghi MA, Mosavi-Jarrahi A, Khatemi-Moghaddam M, Afhami S, Khodai S, Azemoodeh O. Community-based outpatient practice of antibiotics use in Tehran. Pharmacoepidemiology and Drug Safety. 2005/01/05 2005; Vol. 14, issue 2:135-8. [1053-8569: (Print)]
53. Nascimento YDA, Carvalho WDS, Acurcio FDA. Drug-related problems observed in a pharmaceutical care service, Belo Horizonte, Brazil. Revista Brasileira de Ciencias Farmaceuticas/Brazilian Journal of Pharmaceutical Sciences 2009; Vol. 45, issue 2:321-30.
54. Ngoh LN, Shepherd MD. Design, development, and evaluation of visual aids for communicating prescription drug instructions to nonliterate patients in rural Cameroon. Patient Education and Counseling. 1997/03/01 1997; Vol. 30, issue 3:257-70. [0738-3991: (Print)]
55. Odusanya OO, Oyediran MA. The effect of an educational intervention on improving rational drug use. The Nigerian Postgraduate Medical Journal 2004; Vol. 11, issue 2:126-31.
56. Ofori-Adjei D, Arhinful DK. Effect of training on the clinical management of malaria by medical assistants in Ghana. Social Science & Medicine. 1996/04/01 1996; Vol. 42, issue 8:1169-76. [0277-9536: (Print)]
57. Oparah AC, Adje DU, Enato EFO. Outcomes of pharmaceutical care intervention to hypertensive patients in a Nigerian community pharmacy. International Journal of Pharmacy Practice 2006; Vol. 14, issue 2:115-22.
58. Osiri S, Richards M. Primary care treatment of upper respiratory tract infections in NE Thailand by pharmacists and physicians. Journal of Social and Administrative Pharmacy 2001; Vol. 18, issue 6:232-8.
59. Pankonin CA, Higgs P, Reid G, Aitken C. Selling syringes to injecting drug users: a study of five pharmacies in Hanoi, Vietnam. Journal of Infection in Developing Countries. 2008/01/01 2008; Vol. 2, issue 1:51-8. [1972-2680: (Electronic)]
60. Park JS, Ahn CW. Educational program for diabetic patients in Korea--multidisciplinary intensive management. Diabetes Research and Clinical Practice. 2007/04/24 2007; Vol. 77 Suppl 1:S194-8. [0168-8227: (Print)]
61. Perera UA, Angunawela I. Basic drug information to patients attending medical clinics of a teaching hospital. The Ceylon Medical Journal. 1988/03/01 1988; Vol. 33, issue 1:27-9. [0009-0875: (Print)]
62. Perez A, Dennis RJ, Rodriguez B, Castro AY, Delgado V, Lozano JM, et al.An interrupted time series analysis of parenteral antibiotic use in Colombia. Journal of Clinical Epidemiology. 2003/10/22 2003; Vol. 56, issue 10:1013-20. [0895-4356: (Print)]
63. Perez-Cuevas R, Guiscafre H, Munoz O, Reyes H, Tome P, Libreros V, et al.Improving physician prescribing patterns to treat rhinopharyngitis. Intervention strategies in two health systems of Mexico. Social Science & Medicine. 1996/04/01 1996; Vol. 42, issue 8:1185-94. [0277-9536: (Print)]
64. Petkova V. Evaluation of the impact of a pharmaceutical care program on patients with asthma. Ankara Universitesi Eczacilik Fakultesi Dergisi 2005; Vol. 34, issue 4:251-62.
65. Petkova V, Ivanova A, Petrova G. Education of patients with diabetes in the community pharmacies (pilot project in Bulgaria). Ankara Universitesi Eczacilik Fakultesi Dergisi 2006; Vol. 35, issue 2:111-24.
66. Ratanajamit C, Kaewpibal P, Setthawacharavanich S, Faroongsarng D. Effect of pharmacist participation in the health care team on therapeutic drug monitoring utilization for antiepileptic drugs. Journal of the Medical Association of Thailand 2009; Vol. 92, issue 11:1500-7.
67. Rivera S, Lopez Orozco M. Design, implementation and assessment of a health education service on the correct use of drugs in a pediatric Mexican hospital. Diseño, Implementación y Evaluación de un Servicio de Educación Sanitaria Sobre el Uso Correcto de los Medicamentos en un Hospital Pediátrico Mexicano 2006; Vol. 4, issue 1:9-12.
68. Rosen CE, Copp WM, Holmes S. Effectiveness of a specially trained pharmacist in a rural community mental health center. Public Health Reports 1978; Vol. 93, issue 5:464-7.
69. Rosen CE, Holmes S. Pharmacist's impact on chronic psychiatric outpatients in community mental health. American Journal of Hospital Pharmacy. 1978/06/01 1978; Vol. 35, issue 6:704-8. [0002-9289: (Print)]
70. Santos AC, Pereira DA, Da Silva OA, Lopes LC. Pharmacotherapeutic follow-up for patients with pulmonary tuberculosis with Dáder method. Seguimento Farmacoterapêutico em Pacientes com Tuberculose Pulmonar Através da Metodologia Dáder 2006; Vol. 27, issue 3:269-73.
71. Santoso B, Suryawati S, Prawaitasari JE. Small group intervention vs formal seminar for improving appropriate drug use. Social Science & Medicine. 1996/04/01 1996; Vol. 42, issue 8:1163-8. [0277-9536: (Print)]
72. Suryaprakasha Rao P. Hospital pharmacist in geriatric care. Indian Journal of Hospital Pharmacy 1983; Vol. 20, issue 6:229-34.
73. Turnacilar M, Sancar M, Apikoglu-Rabus S, Hursitoglu M, Izzettin FV. Improvement of diabetes indices of care by a short pharmaceutical care program. Pharmacy World and Science 2009; Vol. 31, issue 6:689-95.
74. Udomthavornsuk B, Tatsanavivat P, Patjanasoontorn B, Khomthong R, Bhuripanyo K, Saengnipanthkul S, et al.Intervention of inappropriate antibiotic use at a university teaching hospital. Journal of the Medical Association of Thailand. 1991/10/01 1991; Vol. 74, issue 10:429-36. [0125-2208: (Print)]
75. Wood R, Kaplan R, Bekker LG, Brown S, Rivett U. The utility of pharmacy dispensing data for ART programme evaluation and early identification of patient loss to follow-up. Southern African Journal of HIV Medicine 2008, issue 30:44-50.
76. Adisa R, Fakeye T O. Pharmacists-based intervention strategies to address compliance problems among poorly controlled type 2 diabetes in ambulatory care settings in Nigeria. International Journal of Pharmacy Practice 2012;20:41-2.
77. Pharmacist intervention improves patient adherence to antidepressants. Australian Journal of Pharmacy 2011;92:100.
78. Azzopardi L, Hudson S, Mallia C, Cassar K, Coleiro B, Cassar P J, et al.Pharmaceutical care for rheumatoid arthritis patients on methotrexate attending an outpatient hospital clinic. Rheumatology 2010;49:i130.
79. Correr C J, Melchiors A C, Fernandez-Llimos F, Pontarolo R. Effects of a pharmacotherapy follow-up in community pharmacies on type 2 diabetes patients in Brazil. International journal of clinical pharmacy [Online] 2011; Vol. 33:273-80. Available: http://www.mrw.interscience.wiley.com/cochrane/clcentral/articles/381/CN-00812381/frame.html.
80. Costa C G R, Carnevale R C, Holsback V S S, Braz N C, Santos C Z, Moriel P, et al.Can a year of pharmacotherapeutic follow-up reduce the incidence of drug-related problems and increase CD4 counts in HIV-positive outpatients?. European Journal of Hospital Pharmacy: Science and Practice 2012;19:228.
81. Dewulf N L, Santos V D, Pereira L R, Troncon L E. A structured program of pharmaceutical care benefits outpatients with inflammatory bowel diseases undergoing continuous drug therapy. International Journal of Clinical Pharmacy 2011;140:S207.
82. Dewulf N D L S, Santos V, Pereira L, Troncon L E D A. A structured pharmaceutical care program benefits outpatients with inflammatory bowel diseases. Gastroenterology 2012;34:212.
83. Fahimi F, Sharif-Kashani B, Hossein-Ahmadi Z, Salamzadeh J, Namdar R, Mousavi S, et al.The first pharmacist-based warfarin-monitoring service in Iran. Journal of Pharmaceutical Health Services Research 2011;2:59-62.
84. Farsaei S, Sabzghabaee A M, Zargarzadeh A H, Amini M. Effect of pharmacist-led patient education on glycemic control of type 2 diabetics: A randomized controlled trial. Journal of Research in Medical Sciences 2011;16:43-9.
85. Fuchs S C, Fuchs F D, Moreira L B, Gus M, Wiehe M, Fuchs F C, et al.Efficacy of home blood pressure monitoring on blood pressure control: A randomized controlled trial. Circulation 2010;122:e78.
86. Lavoie K, Moullec G, Blais L, Beauchesne M F, Lemiere C, Labrecque M, et al.The efficacy of brief motivational interviewing to improve medication adherence in poorly controlled, nonadherent asthmatics: Results from a randomised controlled pilot study. Chest 2011;140:915A.
87. Lee W Y, Chan M C, Cheun T K, So K H, Yu C M. Impact of pharmacist counselling service on blood pressure control of borderline hypertensive patients. European Heart Journal 2012;14:A25.
88. Lores Delgado D, Lazo Roblejo Y, Bermudez Camps I B, Zuniga Moro A. Pharmacotherapeutic monitoring in patients with congestive heart failure, dispensarized at the Principal Municipal Pharmacy at Santiago de Cuba. Pharmaceutical Care Espana 2011;13:114-22.
89. Magedanz L, Silliprandi E M, dos Santos R P. Impact of the pharmacist on a multidisciplinary team in an antimicrobial stewardship program: a quasi-experimental study. Int J Clin Pharm 2012;34:290-4.
90. Malaty J, Cook S, Green C. Influence of a pharmacist initiated educational intervention on patients' utilization of fluconazole for vulvovaginal candidiasis in an outpatient setting. Journal of the American Pharmacists Association 2011;51:299-300.
91. Maria Belen F I M B, Jose Manuel F O J M, Isabel M C I, Cristina G P C, Angeles F C A, Elena S Y E, et al.The improvement of adherence to antiretroviral treatment through the pharmaceutical care and the analysis of factors affecting it. European Journal of Hospital Pharmacy: Science and Practice 2012;19:242.
92. Mohammad R A, Kim J J, Donihi A C, Coley K. Impact of hospital-based pharmacist advocates in care transitions: Identification and description of medication related interventions after patient discharge from hospital to home. Pharmacotherapy 2011;31:388e.
93. Mori Alpm, Heimann J C, Dorea E L, Bernik M M S, Storpirtis S. Pharmaceutic guidance to hypertensive patients at USP University Hospital: effect on adherence to treatment. Brazilian Journal of Pharmaceutical Sciences [Online] 2010; Vol. 46:353-62. Available: http://www.mrw.interscience.wiley.com/cochrane/clcentral/articles/752/CN-00789752/frame.html.
94. Moten M, Barner J, Jokerst J. Medication therapy management and diabetes outcomes of diabetic patients who receive clinical pharmacy services. Journal of the American Pharmacists Association 2010;50:312.
95. Ola-Olorun O J, Afolabi M O, Ogunsina A O, Oyebisi T O, Akinyemi O A, Akintomide A O, et al.Exploring medicine information needs of hypertensive patients using short message service (SMS) of mobile phone. Pharmacoepidemiology and Drug Safety 2012;21:116.
96. Olives T D, Patel R G, Nelson R S, Yew A, Joing S, Miner J R. Randomized controlled trial of three instructional modalities for patients prescribed outpatient antibiotics from the ED: The potential of cell phone technology to reach limited health literacy patients. Academic Emergency Medicine 2012;19:S219.
97. Pinelli N R, Clark L M, Malinzak L, Goggins M, Patel A. Pharmacist-managed diabetes and cardiovascular risk reduction clinic in renal transplant recipients: Preliminary findings. American Journal of Transplantation 2012;12:288-9.
98. Saokaew S, Sapoo U, Nathisuwan S, Chaiyakunapruk N, Permsuwan U. Anticoagulation control of pharmacist-managed collaborative care versus usual care in Thailand. Int J Clin Pharm 2012;34:105-12.
99. Shapiro L. Pharmacist intervention boosts patient compliance. Drug Topics 2010;154:27.
100. Tahaineh L, Albsoul-Younes A, Al-Ashqar E, Habeb A. The role of clinical pharmacist on lipid control in dyslipidaemic patients in North of Jordan. International journal of clinical pharmacy [Online] 2011; Vol. 33:229-36. Available: http://www.mrw.interscience.wiley.com/cochrane/clcentral/articles/801/CN-00810801/frame.html.
101. Tse T, Althunian T, Burrows J, Yang I, Masel P. An evaluation of the role and potential benefits of the clinical pharmacists involvement in respiratory outpatient clinic. Respirology 2011;16:52.
102. Aderemi-Williams RI, Igwilo CI. Community pharmacies as possible centres for routine immunization. Nigerian Quarterly Journal of Hospital Medicine 2007; Vol. 17, issue 4:131-3.
103. Anderson S. The state of the worlds pharmacy: a protrait of the pharmacy profession. Journal of Interprofessional Care 2002; Vol. 16:391-404.
104. APAaNAoCDS. Medication Therapy Management in Pharmacy Practice: Core elements of an MTM Service Model Version 2.0. Journal of the American Pharmaceutical Association. American Pharmacists Association and National Association of Chain Drug Stores Foundation, 2008; Vol. 48, issue 3:341-53.
105. Beney J, Bero L, Bond C. Expanding the roles of outpatient pharmacists: effects on health services utilisation, costs, and patient outcomes. The Cochrane Collaboration 2000, issue 3:CD000336.
106. Blenkinsopp A, Anderson C, Armstrong M. Systematic review of the effectiveness of community pharmacy-based interventions to reduce risk behaviours and risk factors for coronary heart disease. Journal of Public Health Medicine 2003; Vol. 25, issue 2:144-53.
107. Christensen DB, Farris KB. Pharmaceutical care in community pharmacies: practice and research in the US. The Annals of Pharmacotherapy 2006; Vol. 40, issue 7-8:1400-6.
108. Fabricant SJ, Hirschhorn N. Deranged distribution, perverse prescription, unprotected use: the irrationality of pharmaceuticals in the developing world. Health Policy and Planning 1987; Vol. 2, issue 3:204-13.
109. International Pharmaceutical Federation. Standards for quality of pharmacy services: Good Pharmacy Practice. International Pharmaceutical Federation, 1997.
110. van der Geest S. The illegal distribution of western medicines in developing countries: pharmacists, drug pedlars, injection doctors and others. a bibliographic exploration. Medical Anthropology 1982:197-216.
111. van der Geest S. Pharmaceuticals in the third world: the local perspective. Social Science & Medicine 1987; Vol. 25, issue 3:273-6.
112. Ghani K, Gillani W, Ghani M. Pharmacy teaching and practices problems in developing countries: review. International Journal of Pharmacy Teaching & Practices 2010;1(1):11-7.
113. Hepler CD, Strand LM. Opportunities and responsibilities in pharmaceutical care. American Journal of Pharmaceutical Education 1990; Vol. 47:533-43.
114. Holloway K. Promoting rational use of medicines. International Network for Rational Use of Drugs News 2006; Vol. 16, issue 1:3-4.
115. Horn E, Jacobi J. The critical care clinical pharmacist: evolution of an essential team member. Critical Care Medicine 2006; Vol. 34, issue 3 Suppl:S46-51.
116. Kaboli P, Hoth A, McClimon B, Schnipper J. Clinical pharmacists and inpatient medical care: a systematic review. Archives of Internal Medicine 2006; Vol. 166, issue 9:955-64.
117. Kamat VR, Nitcher M. Self-Medication And Pharmaceutical Marketing in Bombay, India. Social Science & Medicine 1998; Vol. 47, issue 6:779-94.
118. Kane S, Weber R, Dasta J. The impact of critical care pharmacists on enhancing patient outcomes. Intensive Care Medicine 2003; Vol. 29, issue 5:691-8.
119. Grand AL, Hogerzeil HV, Haaijer-Ruskamp FM. Intervention research in rational use of drugs: a review. Health Policy and Planning 1999; Vol. 14, issue 2:89-102.
120. Lipton H, Bero L, Bird J, McPhee S. The impact of clinical pharmacists' consultation on physicians geriatric drug prescribing. A randomized controlled trial. Medical Care 1992; Vol. 30, issue 7:646-58.
121. Lipton H, Bird J. The impact of clinical pharmacists' consultations on geriatric patients' compliance and medical care use: a randomized controlled trial. Gerontologist 1994; Vol. 34, issue 3:307-15.
122. Nkansah N, Mostovetsky O, Yu C, Chheng T, Beney J, Bond CM, et al.Effect of outpatient pharmacists non-dispensing roles on patient outcomes and prescribing patterns. Cochrane Database of Systematic Reviews 2010, issue 7:CD000336.
123. Royal S, Smeaton L, Avery A, Hurwitz B, Sheikh A. Interventions in primary care to reduce medication related adverse events and hospital admissions: systematic review and meta-analysis. Quality & Safety in Health Care 2006; Vol. 15, issue 1:23-31.
124. Singhal P, Raisch D, Gupchup G. The impact of pharmaceutical services in community and ambulatory care settings: evidence and recommendations for future research. The Annals of Pharmacotherapy 1999; Vol. 33, issue 12:1336-55.
125. Smith F. The quality of private pharmacy services in low and middle-income countries: a systematic review. Pharmacy World & Science 2009; Vol. 31, issue 3:351-61.
126. Tully M, Seston E. Impact of pharmacists providing a prescription review and monitoring service in ambulatory care or community practice. The Annals of Pharmacotherapy 2000; Vol. 34, issue 11:1320-31.
127. WHO. The role of the pharmacist in the health care system. World Health Organization. Geneva: World Health Organization (WHO), 1994.
128. WHO. The role of pharmacist in the health care system. World Health Organization. Geneva: World Health Organization (WHO), 1997.
129. WHO. The role of the pharmacist in self-Care and self-medication. World Health Organization. Geneva: Department of Essential Drugs and Other Medicines World Health Organization, 1998.
130. WHO. New tool to enhance role of pharmacists in health care. World Health Organization 2006.
131. WHO. Medicines use in primary care in developing and transitional countries. World Health Organization. Geneva: WHO, 2009.
132. World Bank Group. Country and lending groups. The World Bank Group. The World Bank Group, 2009.